Profile photo Floriaan Schmidt

Floriaan Schmidt

Associate Professor

Biography

A. Floriaan Schmidt has received training in public health, clinical epidemiology, and mathematics. Floriaan completed a PhD on methods for personalized medicine with the Utrecht University in the Netherlands. Following his PhD, he accepted a position with University College London (UCL). Currently, Floriaan has a joined position with UMC Utrecht and UCL. His research focusses on developing and applying human genetics for drug target validation (Schmidt, Nature Communications 2020 & 2021). Additionally, Floriaan conducts research to improve risk prediction modelling for patient subgroups by integrating electronic healthcare records data with information from multi-model sources including genomics and metabolomics. Floriaan has received funding from the British Heart Foundation, the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Servier, IMI, and Erasmus+.

Recent publications

Cancer incidence and mortality among patients with new-onset atrial fibrillation Nadine Zakkak, Matthew Barclay, Arturo Gonzalez-Izquierdo, Amand Floriaan Schmidt, Gregory Y.H. Lip, Georgios Lyratzopoulos, Rui Providencia
Neoplasia (United States), 2025, vol. 59
Validation of machine learning-based risk stratification scores for patients with acute coronary syndrome treated with percutaneous coronary intervention Mitchel A. Molenaar, Jasper L. Selder, Amand F. Schmidt, Folkert W. Asselbergs, Jelle D. Nieuwendijk, Brigitte van Dalfsen, Mark J. Schuuring, Berto J. Bouma, Steven A.J. Chamuleau, Niels J. Verouden
European Heart Journal - Digital Health, 2024, vol. 5, p.702-711
General and abdominal adiposity and hypertension in eight world regions Bin Zhou, James E. Bennett, Aidan P. Wickham, Rosie K. Singleton, Anu Mishra, Rodrigo M. Carrillo-Larco, Nayu Ikeda, Lakshya Jain, Ana Barradas-Pires, Rachel A. Heap, Victor PF Lhoste, Kate E. Sheffer, Nowell H. Phelps, Archie W. Rayner, Edward W. Gregg, Mark Woodward, Gretchen A. Stevens, Maria LC Iurilli, Goodarz Danaei, Mariachiara Di Cesare, Carlos A. Aguilar-Salinas, Noor Ani Ahmad, Pascal Bovet, Zhengming Chen, Albertino Damasceno, Sarah L. Filippi, Imre Janszky, Andre P. Kengne, Young Ho Khang, Kamlesh Khunti, Avula Laxmaiah, Lee Ling Lim, Lauren Lissner, Paula Margozzini, Jean Claude N. Mbanya, Stephen T. McGarvey, Jonathan E. Shaw, Stefan Söderberg, Luis Adrián Soto-Mota, Junyang Wang, Francesco Zaccardi, Leandra Abarca-Gómez, Mohsen Abbasi-Kangevari, Ulrike Gehring, N. Charlotte Onland-Moret, Amand Floriaan Schmidt, Erik J. Timmermans, Yvonne T. van der Schouw, WM Monique Verschuren, Indah S. Widyahening,
The Lancet, 2024, vol. 404, p.851-863
Influence of stressful life events and personality traits on PLN cardiomyopathy severity E van Drie, S E L Taal, A F Schmidt, T E Verstraelen, R de Brouwer, D Schoormans, P M C Mommersteeg, R A de Boer, A A M Wilde, F W Asselbergs, A F Baas, J P van Tintelen, L M van den Heuvel
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024, vol. 26
Advancing drug development for atrial fibrillation by prioritising findings from human genetic association studies Kishore Kukendrarajah, Aliki Eleni Farmaki, Pier D. Lambiase, Richard Schilling, Chris Finan, Amand Floriaan Schmidt, Rui Providencia
EBioMedicine, 2024, vol. 105
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation Marion van Vugt, Chris Finan, Sandesh Chopade, Rui Providencia, Connie R. Bezzina, Folkert W. Asselbergs, Jessica van Setten, A. Floriaan Schmidt
Genome Medicine, 2024, vol. 16

External positions

Onderzoeker - Onderzoeker - University College London